Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines

BACKGROUND: The ataxia telangiectasia mutated and Rad3-related kinase (ATR) has a key role in the signalling of stalled replication forks and DNA damage to cell cycle checkpoints and DNA repair. It has long been recognised as an important target for cancer therapy but inhibitors have proved elusive....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peasland, A, Wang, L-Z, Rowling, E, Kyle, S, Chen, T, Hopkins, A, Cliby, W A, Sarkaria, J, Beale, G, Edmondson, R J, Curtin, N J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172902/
https://ncbi.nlm.nih.gov/pubmed/21730979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.243
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados